Sesame fractions and lipid profiles: A systematic review and meta-analysis of controlled trials

British Journal of Nutrition

Volumn 115, Issue 5, 2016, Pages 764-773

  Khalesi, Saman ^a   Paukste, Ernesta ^a   Nikbakht, Elham ^b   Khosravi Boroujeni, Hossein ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

CHD; Cholesterol; HDL cholesterol; LDL cholesterol; Sesame; TAG

Indexed keywords

ALPHA TOCOPHEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIGNAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL (TOPIC); FOOD INTAKE; HUMAN; HYPOCHOLESTEROLEMIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; META ANALYSIS; QUALITY CONTROL; RATING SCALE; RISK FACTOR; SENSITIVITY ANALYSIS; SESAME; SYSTEMATIC REVIEW; ANALYSIS; BLOOD; CHEMISTRY; DIETARY FIBER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SESAMUM;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; FATTY ACIDS, MONOUNSATURATED; HUMANS; LIGNANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; SESAMUM; TRIGLYCERIDES; VITAMIN E;

EID: 84958655064     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515005012     Document Type: Article

References (57)

1. Gaziano TA (2005) Cardiovascular disease in the developing world and its cost-effective management. Circulation 112, 3547-3553.
2. Imamura T, Doi Y, Arima H, et al. (2009) LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: The Hisayama study. Stroke 40, 382-388.
3. Matsuura E, Hughes GR & Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7, 558-566.
4. Young I & Woodside J (2001) Antioxidants in health and disease. Am J Clin Pathol 54, 176-186.
5. Stocker R & Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84, 1381-1478.
6. Niki E (2011) Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited. J Clin Biochem Nutr 48, 3.
7. Mozaffarian D, Micha R & Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med 7, e1000252.
8. Kris-Etherton PM (1999) Monounsaturated fatty acids and risk of cardiovascular disease. Circulation 100, 1253-1258.
9. Namiki M (2007) Nutraceutical functions of sesame: A review. Crit Rev Food Sci Nutr 47, 651-673.
10. Sankar D, Rao MR, Sambandam G, et al. (2006aA pilot study of open label sesame oil in hypertensive diabetics. J Med Food 9, 408-412.
11. Matsumura Y (2004) The anti-hypertensive effect of sesamin. In Novel Compounds from Natural Products in the New Millennium: Potential and Challenges, p. 170 [BK-H Tan, B-H Bay and Y-Z Zhu, editors]. Singapore: World Science.
12. Kita S, Matsumura Y, Morimoto S, et al. (1995) Antihypertensive effect of sesamin. II. Protection against twokidney, one-clip renal hypertension and cardiovascular hypertrophy. Biol Pharm Bull 18, 1283-1285.
13. Wu W-H (2007) The contents of lignans in commercial sesame oils of Taiwan and their changes during heating. Food Chem 104, 341-344.
14. Moazzami AA & Kamal-Eldin A (2006) Sesame seed is a rich source of dietary lignans. J Am Oil Chem Soc 83, 719-723.
15. Nakai M, Harada M, Nakahara K, et al. (2003) Novel antioxidative metabolites in rat liver with ingested sesamin. J Agric Food Chem 51, 1666-1670.
16. Lemcke-Norojärvi M, Kamal-Eldin A, Appelqvist L-A, et al. (2001) Corn and sesame oils increase serum γ-tocopherol concentrations in healthy Swedish women. J Nutr 131, 1195-1201.
17. Hirose N, Inoue T, Nishihara K, et al. (1991) Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res 32, 629.
18. Sirato-Yasumoto S, Katsuta M, Okuyama Y, et al. (2001) Effect of sesame seeds rich in sesamin and sesamolin on fatty acid oxidation in rat liver. J Agric Food Chem 49, 2647-2651.
19. Ashakumary L, Rouyer I, Takahashi Y, et al. (1999) Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism 48, 1303-1313.
20. Dhar P, Chattopadhya K, Bhattacharyya D, et al. (2007) Ameliorative influence of sesame lignans on lipid profile and lipid peroxidation in induced diabetic rats. J Agric Food Chem 55, 5875-5880.
21. Ramesh B, Saravanan R & Pugalendi K (2005) Influence of sesame oil on blood glucose, lipid peroxidation, and antioxidant status in streptozotocin diabetic rats. J Med Food 8, 377-381.
22. Farajzadeh Sheikh A, Zahdei Asl S, Asgarisabzkoohi N, et al. (2006) The effects of ground sesame seeds (Ardeh) and sunflower oil on the serum lipid profile of the rats. Iran J Diabetes Lipid Disord 6, 45-50.
23. Wu JH, Hodgson JM, Puddey IB, et al. (2009) Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women. Nutr Metab Cardiovasc Dis 19, 774-780.
24. Sankar D, Rao MR, Sambandam G, et al. (2006bEffect of sesame oil on diuretics or Beta-blockers in the modulation of blood pressure, anthropometry, lipid profile, and redox status. Yale J Biol Med 79, 19-26.
25. Chen P-R, Tsai CE, Chang H, et al. (2005) Sesamol induces nitric oxide release from human umbilical vein endothelial cells. Lipids 40, 955-961.
26. Moher D, Liberati A, Tetzlaff J, et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151, 264-269.
27. van Rosendal SP, Osborne MA, Fassett RG, et al. (2010) Guidelines for glycerol use in hyperhydration and rehydration associated with exercise. Sports Med 40, 113-139.
28. Higgins JP & Green S (2008) Cochrane Handbook for Systematic Reviews of Interventions, vol. 5. Chichester: Wiley Online Library.
29. DerSimonian R & Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7, 177-188.
30. Sankar D, Sambandam G, Rao MR, et al. (2005) Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils. Clin Chim Acta 355, 97-104.
31. Wu JH, Hodgson JM, Puddey IB, et al. (2009) Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women. Nutr Metab Cardiovasc Dis 19, 774-780.
32. Helli B, Mowla K, Mohammadshahi M, et al. (2015) Effect of sesamin supplementation on cardiovascular risk factors in women with rheumatoid arthritis. J Am Coll Nutr (epublication ahead of print version 7 July 2015).
33. Wu WH, Kang YP, Wang NH, et al. (2006) Sesame ingestion affects sex hormones, antioxidant status, and blood lipids in postmenopausal women. J Nutr 136, 1270-1275.
34. Mirmiran P, Bahadoran Z, Golzarand M, et al. (2013) Ardeh (Sesamum indicum) could improve serum triglycerides and atherogenic lipid parameters in type 2 diabetic patients: A randomized clinical trial. Arch Iran Med 16, 652-656.
35. Lemcke-Norojärvi M, Kamal-Eldin A, Appelqvist LA, et al. (2001) Corn and sesame oils increase serum gamma-tocopherol concentrations in healthy Swedish women. J Nutr 131, 1195-1201.
36. Alipoor B, Haghighian MK, Sadat BE, et al. (2012) Effect of sesame seed on lipid profile and redox status in hyperlipidemic patients. Int J Food Sci Nutr 63, 674-678.
37. Khajehdehi P (2000) Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr 10, 191-195.
38. Miyawaki T, Aono H, Toyoda-Ono Y, et al. (2009) Antihypertensive effects of sesamin in humans. J Nutr Sci Vitaminol 55, 87-91.
39. Nordestgaard BG & Varbo A (2014) Triglycerides and cardiovascular disease. Lancet 384, 626-635.
40. Catapano AL, Farnier M, Foody JM, et al. (2014) Combination therapy in dyslipidemia: where are we now? Atherosclerosis 237, 319-335.
41. Banach M (2015) Combination Therapy in Dyslipidemia. Basel, Switzerland: Springer.
42. Banach M, Rizzo M, Toth PP, et al. (2015) Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 11, 1-23.
43. Tsuruoka N, Kidokoro A, Matsumoto I, et al. (2005) Modulating effect of sesamin, a functional lignan in sesame seeds, on the transcription levels of lipid-and alcohol-metabolizing enzymes in rat liver: A DNA microarray study. Biosci Biotechnol Biochem 69, 179.
44. Nakai M, Harada M, Nakahara K, et al. (2003) Novel antioxidative metabolites in rat liver with ingested sesamin. J Agric Food Chem 51, 1666-1670.
45. Schwingshackl L & Hoffmann G (2012) Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients 4, 1989-2007.
46. Harris WS, Mozaffarian D, Rimm E, et al. (2009) Omega-6 fatty acids and risk for cardiovascular disease: A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119, 902-907.
47. Zhu Q, Huang Y & Chen Z (2000) Interaction between flavonoids and alpha-tocopherol in human low density lipoprotein. J Nutr Biochem 11, 14-21.
48. Hemalatha S & Rao M (2004) Sesame lignans enhance antioxidant activity of vitamin E in lipid peroxidation systems. Mol Cell Biochem 262, 195-202.
49. Kamal-Eldin A, Frank J, Razdan A, et al. (2000) Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 35, 427-435.
50. Yamashita K, Iizuka Y, Imai T, et al. (1995) Sesame seed and its lignans produce marked enhancement of vitamin E activity in rats fed a low alpha-tocopherol diet. Lipids 30, 1019-1028.
51. Kang M-H, Katsuzaki H & Osawa T (1998) Inhibition of 2, 2'-azobis (2,4-dimethylvaleronitrile)-induced lipid peroxidation by sesaminols. Lipids 33, 1031-1036.
52. Kang M-H, Naito M, Sakai K, et al. (1999) Mode of action of sesame lignans in protecting lowdensity lipoprotein against oxidative damage in vitro. Life Sci 66, 161-171.
53. Steinbrecher U, Parthasarathy S, Leake D, et al. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 81, 3883-3887.
54. Ide T, Ashakumary L, Takahashi Y, et al. (2001) Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta 1534, 1-13.
55. Umeda-Sawada R, Ogawa M, Nakamura M, et al. (2001) Effect of sesamin on mitochondrial and peroxisomal beta-oxidation of arachidonic and eicosapentaenoic acids in rat liver. Lipids 36, 483-489.
56. Desvergne B & Wahli W (1999) Peroxisome proliferatoractivated receptors: nuclear control of metabolism. Endocr Rev 20, 649-688.
57. Sankar D, Ali A, Sambandam G, et al. (2011) Sesame oil exhibits synergistic effect with anti-diabetic medication in patients with type 2 diabetes mellitus. Clin Nutr 30, 351-358.